Movement Alert｜MEDBOT-B Rises 5.09% in Regular Trading, Surgical Robot Export Surge and First-Ever Half-Year Profit Continue to Boost Sentiment

Market Focus08-07

On August 7, MEDBOT-B rose 5.09% in regular trading, trading at HKD 23.12/share, with turnover of HKD 91.72 million.

On the news front, the company's surgical robot export volume has surged significantly, with overseas scale effects beginning to materialize. The company previously issued a profit alert forecasting first-half net profit of RMB 28-40 million, compared with a net loss of RMB 115 million a year earlier, marking its first-ever half-year profitability. Revenue grew approximately 200%-230% year-over-year, with the core Toumai laparoscopic surgical robot recording overseas revenue growth exceeding 450%. Global commercial installations surpassed 200 units with orders exceeding 300 units, spanning over 60 countries and regions. Additionally, Da Hua Securities initiated coverage with a Buy rating and HKD 29 target price, citing the company's 5G remote surgery capabilities and global expansion prospects, projecting a 73.8% revenue CAGR from 2025 to 2028.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1153120422?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 14:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153120422","market":"hk","top_or_hot":-1,"title":"Movement Alert｜MEDBOT-B Rises 5.09% in Regular Trading, Surgical Robot Export Surge and First-Ever Half-Year Profit Continue to Boost Sentiment","media":"Market Focus","content":"<p><p>On August 7, MEDBOT-B rose 5.09% in regular trading, trading at HKD 23.12/share, with turnover of HKD 91.72 million.</p><p>On the news front, the company's surgical robot export volume has surged significantly, with overseas scale effects beginning to materialize. The company previously issued a profit alert forecasting first-half net profit of RMB 28-40 million, compared with a net loss of RMB 115 million a year earlier, marking its first-ever half-year profitability. Revenue grew approximately 200%-230% year-over-year, with the core Toumai laparoscopic surgical robot recording overseas revenue growth exceeding 450%. Global commercial installations surpassed 200 units with orders exceeding 300 units, spanning over 60 countries and regions. Additionally, Da Hua Securities initiated coverage with a Buy rating and HKD 29 target price, citing the company's 5G remote surgery capabilities and global expansion prospects, projecting a 73.8% revenue CAGR from 2025 to 2028.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜MEDBOT-B Rises 5.09% in Regular Trading, Surgical Robot Export Surge and First-Ever Half-Year Profit Continue to Boost Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜MEDBOT-B Rises 5.09% in Regular Trading, Surgical Robot Export Surge and First-Ever Half-Year Profit Continue to Boost Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-07 14:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 7, MEDBOT-B rose 5.09% in regular trading, trading at HKD 23.12/share, with turnover of HKD 91.72 million.</p><p>On the news front, the company's surgical robot export volume has surged significantly, with overseas scale effects beginning to materialize. The company previously issued a profit alert forecasting first-half net profit of RMB 28-40 million, compared with a net loss of RMB 115 million a year earlier, marking its first-ever half-year profitability. Revenue grew approximately 200%-230% year-over-year, with the core Toumai laparoscopic surgical robot recording overseas revenue growth exceeding 450%. Global commercial installations surpassed 200 units with orders exceeding 300 units, spanning over 60 countries and regions. Additionally, Da Hua Securities initiated coverage with a Buy rating and HKD 29 target price, citing the company's 5G remote surgery capabilities and global expansion prospects, projecting a 73.8% revenue CAGR from 2025 to 2028.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微创机器人-B","start_time":0,"source_url":"","article_id":"1153120422","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153120422","pubTimestamp":1786085120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 7, MEDBOT-B rose 5.09% in regular trading, trading at HKD 23.12/share, with turnover of HKD 91.72 million.On the news front, the company's surgical robot export volume has surged...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"动态警报|MEDBOT-B常规交易上涨5.09%，手术机器人出口激增，首次半年盈利继续提振市场情绪","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"On August 7, MEDBOT-B rose 5.09% in regular trading, trading at HKD 23.12/share, with turnover of HKD 91.72 million.On the news front, the company's surgical robot export volume has surged significantly, with overseas scale effects beginning to materialize. The company previously issued a profit alert forecasting first-half net profit of RMB 28-40 million, compared with a net loss of RMB 115 million a year earlier, marking its first-ever half-year profitability. Revenue grew approximately 200%-230% year-over-year, with the core Toumai laparoscopic surgical robot recording overseas revenue growth exceeding 450%. Global commercial installations surpassed 200 units with orders exceeding 300 units, spanning over 60 countries and regions. Additionally, Da Hua Securities initiated coverage with a Buy rating and HKD 29 target price, citing the company's 5G remote surgery capabilities and global expansion prospects, projecting a 73.8% revenue CAGR from 2025 to 2028.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153120422","isCrawlerRequest":true}